Re Agreement

GB Group PLC 16 December 2002 16 December 2002 GB Group plc GB Announces Agreement With AstraZeneca for Global Pharmaceutical Stock Data Analysis Project GB Group plc today announces that it has signed an agreement with AstraZeneca to provide software and service solutions which support the Company's global inventory management system. Under the agreement, which is worth an initial £0.2 million, GB Group will supply an Alterian based solution package and its own tailored consultancy service to AstraZeneca. The project has been established to help with the analysis, reporting and the data management of its global pharmaceutical stocks by country and to increase the speed of the flow of its data. By providing the services under the agreement, AstraZeneca confidently expects to make significant cash savings in the area of stock management. Richard Law, GB Group's Chief Executive, said: 'I am delighted with our agreement with AstraZeneca. This is the first deal to be closed from the pipeline of sales opportunities that GB Group acquired when it bought eWare Interactive Limited on 1 November 2002 and I am confident that more will follow. With the combination of eWare Interactive and GB Group's own operations, we have established ourselves as a market-leader in data analytics and we have demonstrated our ability to provide an effective solution to a client's data issue and help improve processes and profitability.' For further information, please contact: GB Group plc 01244 657333 Richard Law, Chief Executive Weber Shandwick Square Mile 020 7067 0700 Richard Hews Christian San Jose Website www.gb.co.uk Notes for Editors: 1. GB Group plc is a listed company based in Chester. GB Group's clients include Coral, De Vere Hotels, Bank of Ireland, npower, WHSmith - plus many government agencies, such as HM Customs & Excise, National Criminal Intelligence Service and the National Crime Squad. GB Group is a business partner of Alterian plc. 2. AstraZeneca is one of the world's leading pharmaceutical companies. Backed by a strong research base and extensive manufacturing and commercial skills, it provides innovative, effective medicines that make a real difference for patients in important areas of healthcare. 3. Alterian plc is a listed company based in Bristol. Alterian's software solutions deliver sophisticated analysis across vast data sets, handling complex queries at train-of-thought speed. Users gain actionable insight on their operational data and receive a rapid return on their investment. Alterian business partners take the software to construct a product or service or deliver a tailored solution to their customers. This information is provided by RNS The company news service from the London Stock Exchange

Companies

GB Group (GBG)
UK 100

Latest directors dealings